The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and cardiovascular death among adults with type 2 diabetes and chronic kidney disease, Novo Nordisk announced. Semaglutide 1 mg (Ozempic, Novo Nordisk) is a once-weekly subcutaneous GLP-1 originally approved to improve glycemic control for adults with type 2 diabetes in December
Childhood obesity has increased substantially over the last 30 years, with 8% (160 million) of children worldwide living with obesity in 2022. Obesity is associated…
There is a certain kind of poetry associated with the human heart. “People are aware of the heart, there is a glamor associated with it,”…
The Endocrine Society examines the recent release of the LHHS Appropriations Subcommittee bill as well as the CMS proposed physician fee schedule rule for FY24.
Medicare beneficiaries with emphysema who received an endobronchial valve vs. lung volume reduction surgery faced elevated risk-adjusted odds for poor outcomes, according to data presented…
The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic cancer, according to results of a randomized…
Senators grilled Robert F. Kennedy Jr. about his views on vaccines, abortion and other health-related matters in a frequently contentious hearing Wednesday to assess his…
Researchers have identified two microRNA that may predict which individuals with cancer are at elevated risk for COVID-19-related death.Low levels of hsa-miR-150-5p and hsa-miR-93-5p in…
SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.
The Women’s Interprofessional Network of the American Diabetes Association (WIN ADA) is our members-only network for female clinicians, scientists, educators, and other health professionals in…
The American Diabetes Association’s (ADA’s) Standards of Care in Diabetes (Standards of Care), as well as other health care leaders and government institutions, recognize obesity…
